JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46 | -99.9% | 25,000 | +25.0% | 0.00% | 0.0% |
| Q3 2022 | $47,000 | -23.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $61,000 | -55.1% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $136,000 | -18.6% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $167,000 | +125.7% | 20,000 | +100.0% | 0.00% | +200.0% |
| Q3 2021 | $74,000 | -71.0% | 10,000 | 0.0% | 0.00% | -80.0% |
| Q2 2021 | $255,000 | +147.6% | 10,000 | 0.0% | 0.01% | +150.0% |
| Q1 2021 | $103,000 | +47.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | -14.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $82,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |